Surmodics reported $6.32M in Stock for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Align Technology ALGN:US $ 178.75M 28.11M
Arrowhead Research ARWR:US 0 0
Baxter International BAX:US $ 2065M 48M
Bioscrip BIOS:US $ 173.85M 0.23M
Edwards Lifesciences EW:US $ 759.5M 8.4M
Genmark Diagnostics GNMK:US $ 21.32M 1.75M
Haemonetics HAE:US $ 326.5M 3.89M
Heron Therapeutics HRTX:US $ 42.8M 0.17M
Mesa Laboratories MLAB:US $ 12.12M 0.94M
Nektar Therapeutics NKTR:US $ 14.62M 2.19M
Oxford Immunotec Global OXFD:US $ 13.1M 0.28M
Stryker SYK:US $ 3431M 42M
Surmodics SRDX:US $ 6.32M 0.01M